Shardea Turney
Family · Rochester, MINPI 1841882479
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 37.9% of the total. Reporting peaked in 2023 at $4,679 and has fallen 88.9% since, to $522 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $58.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- Relievant Medsystems, Inc.$1K
- Nalu Medical, Inc.$830
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$609
- Collegium Pharmaceutical, Inc.$338
- plus $630 from 10 others
What the payments were for
- Travel & lodging$5,11252%
- Food & beverage$4,67947%
- Education$1081%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 31 | $3,753 |
| Boston Scientific | 41 | $2,442 |
| Relievant Medsystems, Inc. | 5 | $1,297 |
| Nalu Medical, Inc. | 3 | $830 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 50 | $609 |
| Collegium Pharmaceutical, Inc. | 19 | $338 |
| Nevro Corp. | 1 | $141 |
| Vertex | 2 | $102 |
| AbbVie | 5 | $83 |
| Si-bone, Inc. | 3 | $76 |
| SPR Therapeutics, Inc | 3 | $67 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Saluda Medical Americas, Inc. | 2 | $36 |
| Spinal Simplicity, LLC | 1 | $30 |
| Averitas Pharma Inc. | 1 | $30 |
| Valinor Pharma, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,295
- SYNCHROMEDII$1,550
- Superion Indirect Decompression System$1,492
- VANTA ADAPTIVESTIM$1,176
- Nalu Neurostimulation System$798
- Omnia$141
- INTELLIS ADAPTIVESTIM$108
How this compares
$9,899 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,439 | $31,853 |
| BelbucaBuprenorphine Hcl | 31 | $26,756 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 878 | $25,902 |
| MovantikNaloxegol Oxalate | 18 | $7,161 |
| LinzessLinaclotide | 12 | $6,141 |
| Gabapentin | 456 | $5,896 |
| OxycontinOxycodone Hcl | 12 | $5,596 |
| Lidocaine | 33 | $5,342 |
| Oxycodone Hcl | 267 | $4,674 |
| Pregabalin | 153 | $3,527 |
| Morphine Sulfate ErMorphine Sulfate | 116 | $3,373 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,860 |
| Nortriptyline Hcl | 288 | $2,767 |
| Diclofenac Sodium | 181 | $2,727 |
| Tizanidine Hcl | 230 | $2,434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $338 | $26,75631 claims |
| AbbVieLinzess | $83 | $6,14112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Rochester
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.